PF-04217903

DB12848InvestigationalSmall molecule

PF-04217903 has been used in trials studying the treatment of Neoplasms.

Chemical structure of PF-04217903
Mechanism
Curator reviewed
Formula / weight
C19H16N8O · 372.392 g/mol (avg)
Code names
MET TYROSINE KINASE INHIBITOR PF-04217903 · PF-4217903

Resolves to

Compound
UNIICYJ9ATV1IJCAS956905-27-4ChEMBLCHEMBL2001019ChEBI91425PubChem17754438
Structure
InChIKeyPDMUGYOXRHVNMO-UHFFFAOYSA-NSMILESOCCN1C=C(C=N1)C1=CN=C2N=NN(CC3=CC4=CC=CN=C4C=C3)C2=N1
Targets
P08581MET

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PF-04217903, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In